OakChart

Jin Medical International Ltd

ZJYLHealthcare·Medical Instruments & Supplies·China·Small·NASD·Nov 11 • 3:59 PM ET

4.91+0.70 (16.63%)
2026-11-12 05:36 CET
Market cap
776.74 USD m
Revenue, TTM
19.73 USD m
Net income, TTM
1.17 USD m
Free cash flow, TTM
-6.96 USD m
EPS diluted, TTM
0.15
P/E
32.78
Compare

Price

ZJYL against its 20, 50 and 200-day averages
2050200
2.004.006.0010.0M20.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ZJYLclose 4.9120-day 2.6150-day 2.26200-day 2.384.9152w high52w low

15.0% under the 52-week high of 5.78 on 10 Nov 2025. 52-week low 1.53 on 6 Aug 2026. Last 15 sessions, 170.5% high to low

Volume 1.63× normal · the line is the 50-bar volume average

Profile

ZJYL
52-week range, 81% of the way up
1.535.68

Jin Medical International Ltd. is a holding company. It is engaged in the design, development, manufacturing, and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China.

Employees295
IPOMar 28, 2023
Beta7.00
ATR, 14d0.35
Rel volume1.63
Short float0.01%
Insider own8.63%
Inst own0.01%

Snapshot

6 groups

Valuation

Index-
Market Cap776.74M
Enterprise Value767.05M
Income1.17M
Sales19.73M
Book/sh3.87
Cash/sh0.19
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees295
IPOMar 28, 2023

Ratios

P/E32.78
Forward P/E-
PEG-
P/S39.37
P/B1.27
P/C25.81
P/FCF-
EV/EBITDA1095.78
EV/Sales38.88
Quick Ratio1.64
Current Ratio1.95
Debt/Eq0.68
LT Debt/Eq0.09
Option/ShortNo / Yes

Earnings

EPS (ttm)0.15
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-23.37% -11.20%
Sales past 3/5Y2.53% 5.02%
EPS Y/Y TTM-34.59%
Sales Y/Y TTM-13.59%
EPS Q/Q-21.05%
Sales Q/Q-9.74%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own8.63%
Insider Trans0.00%
Inst Own0.01%
Inst Trans6.88%
ROA2.25%
ROE4.03%
ROIC3.53%
Gross Margin30.62%
Oper. Margin2.12%
Profit Margin5.94%
SMA2087.98%
SMA50116.85%
SMA200106.48%
Trades-

Technical

Shs Outstand158.19M
Shs Float144.54M
Short Float0.01%
Short Ratio0.05
Short Interest0.01M
52W High5.68 -13.53%
52W Low1.53 220.92%
Volatility14.09% 13.45%
ATR (14)0.35
RSI (14)87.31
Beta7.00
Rel Volume1.63
Avg Volume140.15K
Volume228,836

Performance

Perf Week58.90%
Perf Month138.35%
Perf Quarter50.61%
Perf Half Y100.41%
Perf YTD11.59%
Perf Year-1.88%
Perf 3Y-46.22%
Perf 5Y-
Perf 10Y-
Recom-
Target Price-
Prev Close4.21
Price4.91
Change %16.63%

Peers

Mkt cap
TickerCompanyMkt cap
INGNInogen Inc149.51M
LFWDLifeward Ltd16.31M
MYOMyomo Inc50.13M
AHCOAdaptHealth Corp1.06B
ELMDElectromed Inc206.84M
TCMDTactile Systems Technology Inc607.74M
WOKWork Medical Technology Group Ltd6.12M
VMDViemed Healthcare Inc345.96M
AHGAkso Health Group ADR1.15B
ITOCiTonic Holdings Ltd15.72M

News

latest 14 of 56
  • Jin Medical Supports the 12th Jiangsu Provincial Games for Persons with Disabilities with Professional Wheelchairs and Accessibility Services (PR Newswire) +23.64%
  • JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results (PR Newswire) +13.92%
  • Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement (PR Newswire)
  • Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative (PR Newswire) -18.34%
  • Jin Medical CEO Fireside Chat (PR Newswire)
  • Jin Medical International Ltd. To Host Management Fireside Chat (PR Newswire)
  • Jin Medical Announces the Official Commencement Date of Chuzhou Facility (PR Newswire)
  • Jin Medical International Ltd. Management Plans For Fireside Chat (GlobeNewswire)
  • Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility (GlobeNewswire) +6.46%
  • Jin Medical International Ltd. - Nasdaq Minimum Bid Price Non-Compliance (GlobeNewswire)
  • Construction of JinMed's New Facility Begins in Chuzhou, China (GlobeNewswire)
  • 7 A-Rated Penny Stocks to Beat June Gloom (InvestorPlace)
  • Why Is Jin Medical International (ZJYL) Stock Moving Today? (InvestorPlace) +19.44%
  • Take Profit: 3 Stocks to Sell That Are Up More Than 500% in 2023 (InvestorPlace) -21.19% -36.87%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual0.4560.2760.3290.3380.3950.470.152
Period2019202020212022202320242025
EPS, quarterly
Period
Sales, annual20.36716.19420.76419.19119.82123.50220.687
Period2019202020212022202320242025
Sales, quarterly
Period
Shares, annual88887.7977.8277.827
Period2019202020212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue19.7320.6923.5019.8219.1920.7616.1920.37
Cost of Goods Sold Incl. D&A13.6914.6414.0013.0412.9914.4010.7012.86
Gross Profit6.046.049.506.786.206.365.507.51
Selling, General and Administrative Excl. Other5.625.445.863.924.073.733.143.11
Research and Development1.781.561.501.541.891.571.261.13
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income0.420.613.642.872.132.632.354.40
Interest Expense-----0.010.110.02
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes1.261.604.183.222.742.882.354.13
Income Taxes0.100.210.760.340.040.250.150.48
Consolidated Net Income1.161.383.422.882.712.632.213.65
Net Income From Continuing Operations1.171.193.682.882.712.632.213.65
Net Income1.171.193.682.882.712.632.213.65
EPS (Recurring)0.150.150.470.400.340.330.280.46
EPS (Basic, Before Extraordinaries)0.150.150.470.400.340.330.280.46
EPS (Diluted)0.150.150.470.400.340.330.280.46
EBITDA0.700.933.973.092.492.972.684.75
Non-Operating Income (Expense)0.840.990.540.350.610.260.11-0.25
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Earnings Ratio32.7832.7857,849.46-----
Price To Sales Ratio0.804.2817.928.59----
Gross Margin30.6229.2240.4334.2332.3030.6433.9536.88
Operating Margin2.122.9415.4814.4711.1012.6714.5421.62
Net Margin5.945.7615.6414.5214.1012.6713.6217.91
Shares Outstanding7.837.837.837.808.008.008.008.00
Market Capitalization776.74776.74168,444.573,627.003,627.00---

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S22023S1
Total Revenue8.9210.819.8812.9510.569.5710.25
Cost of Goods Sold Incl. D&A6.527.167.487.186.826.316.72
Gross Profit2.403.642.405.773.743.253.53
Selling, General and Administrative Excl. Other3.042.582.863.362.512.161.76
Research and Development0.880.900.660.890.610.910.63
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-0.641.06-0.452.411.231.101.77
Interest Expense---0.22---
Unusual Expense0.000.000.000.000.000.000.00
Net Income Before Taxes-0.311.570.032.172.011.251.97
Income Taxes-0.100.200.020.450.310.140.20
Consolidated Net Income-0.211.370.011.721.701.111.77
Net Income From Continuing Operations-0.111.28-0.091.881.791.111.77
Net Income-0.111.28-0.091.881.791.111.77
EPS (Recurring)-0.010.16-0.010.240.230.130.26
EPS (Basic, Before Extraordinaries)-0.010.16-0.010.240.230.140.26
EPS (Diluted)-0.010.16-0.010.240.230.130.26
EBITDA-0.491.20-0.262.581.391.201.88
Non-Operating Income (Expense)0.340.500.48-0.020.780.160.20
Price To Earnings Ratio32.7819,824.5612,653.6257,849.466,536.17--
Price To Sales Ratio0.804.285.1017.9229.849.79-
Gross Margin26.8833.7024.3144.5535.3934.0134.44
Operating Margin-7.239.83-4.6018.6111.6411.4517.28
Net Margin-1.2111.85-0.9014.5416.9911.6217.23
Shares Outstanding7.837.837.837.837.837.807.75
Market Capitalization776.7435,379.6246,550.82168,444.57240,456.193,627.001,192.00

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments29.6326.7616.707.075.732.843.34
Short Term Receivables6.808.788.504.255.987.868.63
Inventories6.957.125.866.887.047.275.74
Other Current Assets0.650.170.06----
Total Current Assets44.0442.8231.1218.2018.7517.9717.70
Net Property, Plant & Equipment7.981.721.481.632.112.312.38
Total Investments and Advances0.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.00
Deferred Tax Assets0.140.120.150.250.180.170.09
Other Assets1.211.150.150.860.860.370.19
Total Assets53.3745.8032.9020.9421.9020.8220.36
Short Term Debt Incl. Current Port. of LT Debt18.5011.274.110.000.002.652.87
Accounts Payable3.263.013.394.115.355.434.76
Income Tax Payable0.260.810.260.170.100.080.45
Other Current Liabilities1.782.061.161.422.421.861.58
Total Current Liabilities23.8017.158.925.707.8710.019.66
Long Term Debt0.000.100.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.00
Total Liabilities23.8017.258.925.707.8710.019.66
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00
Common Equity29.6428.8223.9815.2414.0310.8010.71
Total Shareholders Equity29.6428.8223.9815.2414.0310.8010.71
Accumulated Minority Interest-0.07-0.260.000.000.000.000.00
Total Equity29.5728.5523.9815.2414.0310.8010.71
Total Liabilities & Stockholders Equity53.3745.8032.9020.9421.9020.8220.36
Book Value Per Share3.793.683.081.901.751.351.34
Tangible Book Value Per Share3.793.683.081.901.751.351.34
Full-Time Employees295269245269291263341
Price to Book Ratio1.276,418.52154.04154.04---
Return on Assets2.409.3410.6912.6412.3210.71-
Return on Equity4.0813.9314.6818.5021.2020.51-
Return on Invested Capital4.0212.7112.0017.7618.7620.4234.07
Quick Ratio1.562.082.831.981.491.071.24
Current Ratio1.852.503.493.192.381.791.83

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income1.161.383.422.882.712.632.213.65
Depreciation0.290.320.330.220.360.340.320.34
Other Funds (Non Cash)-0.160.12-0.070.120.03-0.090.090.03
Funds from Operations1.191.813.713.313.012.882.543.99
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-1.781.10-4.92-0.20-1.432.96-0.03-5.32
Income Taxes Payable-0.30-0.790.820.030.16-0.10-0.310.07
Cash from Operating Activities-0.592.90-1.213.111.585.842.50-1.33
Capital Expenditures-6.37-6.63-1.12-0.11-0.04-0.04-0.14-0.07
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.010.000.000.000.00
Purchase or Sale of Investments-0.02-3.66-8.39-7.63-0.45-0.810.290.15
Purchase of Investments-6.99-9.70-21.05-12.05-5.65-4.96-9.06-14.55
Sale Or Maturity of Investments6.976.0412.664.435.204.159.3514.69
Other Uses0.00-0.500.000.000.00-0.22-2.100.00
Other Sources0.000.000.000.000.360.000.000.05
Cash from Investing Activities-6.38-10.79-9.51-7.73-0.12-1.07-1.960.13
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock-0.10-0.100.317.120.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock-0.10-0.100.317.120.000.000.000.00
Proceedsfrom Stock Options-0.10-0.100.317.120.000.000.000.00
Issuance or Reduction of Debt, Net4.197.596.874.250.00-2.77-0.362.27
Change in Long Term Debt2.830.000.000.000.000.000.000.00
Issuance of Long Term Debt2.830.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.46-0.134.48-4.470.12-0.100.010.09
Other Financing Activities Uses--0.13--4.470.00-0.100.000.00
Cash from Financing Activities4.547.3511.656.910.12-2.87-0.342.36
Exchange Rate Effect0.38-0.140.27-0.15-0.460.10-0.48-0.07
Net Change in Cash-2.05-0.671.212.141.122.01-0.281.09
Free Cash Flow-6.96-3.73-1.352.991.545.802.36-1.40
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow---56.93----
Deferred Taxes & Investment Tax Credit--0.020.040.09-0.09-0.00-0.08-0.03

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Cash & Short Term Investments30.1029.6330.9626.7625.9916.70
Short Term Receivables6.656.806.148.785.548.50
Inventories7.126.956.107.126.375.86
Other Current Assets0.580.650.590.170.280.06
Total Current Assets44.4544.0443.7842.8238.1831.12
Net Property, Plant & Equipment9.907.983.511.721.731.48
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets-0.000.000.000.000.00
Deferred Tax Assets0.240.140.130.120.130.15
Other Assets1.251.211.091.151.120.15
Total Assets55.8453.3748.5245.8041.1632.90
Short Term Debt Incl. Current Port. of LT Debt17.7118.5015.6811.279.684.11
Accounts Payable2.603.263.063.013.153.39
Income Tax Payable0.230.260.610.810.550.26
Other Current Liabilities2.281.781.402.061.461.16
Total Current Liabilities22.8223.8020.7417.1514.838.92
Long Term Debt2.870.000.030.100.180.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities25.6923.8020.7717.2515.018.92
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity30.3229.6427.9128.8226.2423.98
Total Shareholders Equity30.3229.6427.9128.8226.2423.98
Accumulated Minority Interest-0.17-0.07-0.16-0.26-0.090.00
Total Equity30.1529.5727.7628.5526.1523.98
Total Liabilities & Stockholders Equity55.8453.3748.5245.8041.1632.90
Book Value Per Share3.873.793.573.683.353.08
Tangible Book Value Per Share3.873.793.573.683.353.08
Price to Book Ratio1.271,267.531,615.476,418.529,989.59154.04
Return on Assets2.252.404.009.348.05-
Return on Equity4.034.086.6213.9311.67-
Return on Invested Capital-0.324.32-0.326.516.794.64
Quick Ratio1.641.561.822.082.152.83
Current Ratio1.951.852.112.502.583.49

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Net Income-0.211.370.011.721.701.11
Depreciation0.150.140.190.170.160.11
Other Funds (Non Cash)-0.290.13-0.010.02-0.09-0.06
Funds from Operations-0.441.630.181.911.801.19
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.49-1.292.39-3.17-1.75-0.82
Income Taxes Payable-0.02-0.28-0.520.530.29-0.05
Cash from Operating Activities-0.930.342.56-1.260.050.36
Capital Expenditures-1.79-4.58-2.05-0.06-1.06-0.10
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.01
Purchase or Sale of Investments2.01-2.02-1.64-1.06-7.33-5.32
Purchase of Investments-2.57-4.42-5.28-4.92-16.14-8.90
Sale Or Maturity of Investments4.582.393.643.858.813.58
Other Uses0.000.00-0.500.000.004.76
Other Sources0.000.000.00-4.244.240.00
Cash from Investing Activities0.22-6.60-4.19-5.36-4.15-0.66
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.00-0.100.000.000.310.34
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.00-0.100.000.000.310.34
Proceedsfrom Stock Options0.00-0.100.000.000.310.34
Issuance or Reduction of Debt, Net1.402.794.801.315.552.82
Change in Long Term Debt2.830.000.000.000.000.00
Issuance of Long Term Debt2.830.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.69-0.230.104.340.14-4.35
Other Financing Activities Uses------4.35
Cash from Financing Activities2.092.454.905.656.00-1.19
Exchange Rate Effect0.240.14-0.280.230.04-0.27
Net Change in Cash1.62-3.673.00-0.741.95-1.75
Free Cash Flow-2.72-4.240.51-1.32-0.030.26
Price to Free Cash Flow----2,653.9164.83

Revenue breakdown

Other Products2024: 6.75M 2025: 2.58M
Wheelchair2024: 14.87M 2025: 16.22M
Wheelchair Components2024: 1.88M 2025: 1.89M
China Domestic Market2024: 8.61M 2025: 4.41M
Overseas Market2024: 14.89M 2025: 16.27M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.01%0.0M144.5M768.74K
2026-10-150.03%0.0M144.5M712.57K
2026-09-300.05%0.1M134.9M723.53K
2026-09-150.12%0.1M64.7M730.56K
2026-08-310.10%0.1M64.7M950.03K
2026-08-142.62%0.1M5.7M969.42K
2026-07-310.18%0.0M1.8M285.33K
2026-07-150.88%0.0M1.8M288.14K
2026-06-300.43%0.0M1.8M287.78K
2026-06-151.03%0.0M1.8M283.48K
2026-05-290.60%0.0M1.8M18.55K
2026-05-150.71%0.0M1.8M19.07K
2026-04-300.63%0.0M1.8M20.12K
2026-04-151.55%0.0M1.0M38.24K
2026-03-31-0.0M-40.32K
2026-03-13-0.0M-34.38K
2026-02-270.44%0.0M2.0M30.54K
2026-02-130.40%0.0M2.0M30.61K
2026-01-300.46%0.0M1.9M57.93K
2026-01-150.43%0.0M1.9M55.65K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-30SEC
2026-09-25SCHEDULE 13D/ASEC
2026-09-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-24SEC
2026-09-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-08SEC
2026-08-21SCHEDULE 13DSEC
2026-08-18SCHEDULE 13GSEC
2026-08-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-07-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-20SEC
2026-07-163Initial statement of beneficial ownership of securities2026-07-16SEC
2026-07-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-15SEC
2026-06-306-K/A2026-06-30SEC
2026-06-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-29SEC
2026-06-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-04SEC
2026-05-063Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-273Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-243Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-243Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-243Initial statement of beneficial ownership of securities2026-03-18SEC
2026-04-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-07SEC
2026-03-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-17SEC
2026-02-1020-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-09-30SEC
2026-02-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-09SEC
2026-02-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-04SEC
2026-01-30NT 20-F2025-09-30SEC
2026-01-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-28SEC
2026-01-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-22SEC
2026-01-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-21SEC
2026-01-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-08SEC
2025-09-09EFFECTEffectiveness filing by commission orderSEC
2025-09-05CORRESPSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HRT FINANCIAL LP0.20%
OSAIC HOLDINGS, INC.0.04%
UBS Group AG0.01%
Caitong International Asset Management Co., Ltd0.00%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.07%

OakChart. ZJYL. Cached 15 minutes.

Some panels did not load: ratings, insider.